Dexcom Inc (DXCM) 13F Investor Activity Report (Q2 2026)

DXCM ranks #498 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

983 institutions disclose a position in DXCM, but none treat it as a major bet — even Castle Hook Partners LP, its most concentrated holder, allocates just 1.2% of its own portfolio to it.

Chicago Capital, LLC has added to its DXCM position for two straight quarters, increasing it by $28.3M to reach $74.6M today.

Assenagon Asset Management S.A. has trimmed its DXCM position for two straight quarters, cutting it by $84.6M while still holding $23.4M.

DXCM is down 1.9% today, but institutions show net buying of $4.6B this quarter — a divergence between today's price move and the underlying institutional flow.

DXCM posted net income of $999.7M over the trailing twelve months, and currently trades at a P/E of 34.9.

• Profitable — net income of $999.7M over the trailing twelve months
• Revenue grew 15.5% year over year
• Net income improved year over year, from $571.5M to $999.7M
• Generated $1.4B in positive operating cash flow
• Current ratio of 1.88x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.31x equity — within a conventional range